Species |
Human |
Protein Construction |
HGFR/c-MET (Glu25-Thr932) Accession # P08581 |
Poly-His |
Avi |
N-term |
|
C-term |
|
Purity |
> 95% as analyzed by SDS-PAGE > 95% as analyzed by HPLC |
Endotoxin Level |
≤ 1 EU/μg of protein by LAL method |
Biological Activity |
Immobilized Human c-MET, His & Avi Tag at 2.0 μg/ml (100 μl/Well). Dose response curve for Human HGF, hFc Tag with the EC50 of 0.16 μg/ml determined by ELISA. |
Expression System |
Expi293 |
Apparent Molecular Weight |
80~85 kDa, on SDS-PAGE under reducing conditions. |
Formulation |
Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4. Normally 5 % trehalose is added as protectant before lyophilization. |
Reconstitution |
It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in distilled water up to 100 μg/ml. |
Storage & Stability |
Upon receiving, this product remains stable for up to 6 months at -70°C or -20°C. Avoid repeated freeze-thaw cycles. |
Immobilized Human c-MET, His & Avi Tag at 2 μg/ml (100 μl/Well). Dose response curve for Human HGF, hFc Tag with the EC50 of 0.16 μg/ml determined by ELISA.
Human HGFR/c-MET on SDS-PAGE under reducing conditions. The purity is greater than 95%.
The purity of Human HGFR/c-MET is greater than 95% as determined by SEC-HPLC.
Target Background |
c-Met, also called tyrosine-protein kinase Met or hepatocyte growth factor receptor (HGFR), is a protein that in humans is encoded by the MET gene. The protein possesses tyrosine kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling. |
Synonyms |
MET; oncogene MET; Proto-oncogene c-Met; HGF R; HGF receptor; HGF/SF receptor; HGFR; AUTS9; cMET; c-MET; EC 2.7.10; EC 2.7.10.1; hepatocyte growth factor receptor; Met (c-Met); met proto-oncogene (hepatocyte growth factor receptor); met proto-oncogene tyrosine kinase; RCCP2; Scatter factor receptor; SF receptor; Tyrosine-protein kinase Met |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.